Cargando…

Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer.

Levels of the tumour markers neurone specific enolase (NSE), lactate dehydrogenase (LDH), chromogranin A (ChrA) and carcinoembryonic antigen (CEA) were measured in serum taken at presentation and during treatment, remission and relapse from 154 patients who received chemotherapy for small cell lung...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, P. W., Joel, S. P., Love, S., Butcher, M., Pandian, M. R., Squires, L., Wrigley, P. F., Slevin, M. L.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1993
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968374/ https://www.ncbi.nlm.nih.gov/pubmed/8385978

Ejemplares similares

Oral urea in the treatment of secondary tumours in the liver.
por: Clark, P. I., et al.
Publicado: (1988)

The effect of food and concurrent chemotherapy on the bioavailability of oral etoposide.
por: Harvey, V. J., et al.
Publicado: (1985)

Double modulation of 5-fluorouracil with interferon alpha 2a and high-dose leucovorin: a phase I and II study.
por: Seymour, M. T., et al.
Publicado: (1994)

A less toxic regimen of 5-fluorouracil and high-dose folinic acid for advanced gastrointestinal adenocarcinomas.
por: Johnson, P. W., et al.
Publicado: (1991)

Frequency of serum tumour marker monitoring.
por: Colls, B. M.
Publicado: (1991)

Clinical evaluation of serum tumour marker CA 242 in non-small cell lung cancer.
por: Pujol, J. L., et al.
Publicado: (1993)

Phase II trial of UFT in advanced colorectal and gastric cancer.
por: Malik, S. T., et al.
Publicado: (1990)

Medroxyprogesterone acetate (MPA) in advanced granulosa cell tumours of the ovary--a new therapeutic approach?
por: Malik, S. T., et al.
Publicado: (1991)

Continuous infusional topotecan in advanced breast and non-small-cell lung cancer: no evidence of increased efficacy.
por: Mainwaring, P. N., et al.
Publicado: (1997)

Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy
por: Tuxen, M K, et al.
Publicado: (2001)

Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours.
por: Seckl, M. J., et al.
Publicado: (1990)

The value of tumour markers in lung cancer.
por: Gomm, S. A., et al.
Publicado: (1988)

Iron status markers in patients with small cell carcinoma of the lung. Relation to survival.
por: Milman, N., et al.
Publicado: (1991)

Baseline tumour measurements predict survival in advanced non-small cell lung cancer
por: Gerber, D E, et al.
Publicado: (2013)

Patient compliance with prolonged low-dose oral etoposide for small cell lung cancer.
por: Lee, C. R., et al.
Publicado: (1993)

Survival in Patients with Neuroendocrine Tumours of the Small Intestine: Nomogram Validation and Predictors of Survival
por: Levy, Sonja, et al.
Publicado: (2020)

Role of tumour markers in monitoring epithelial ovarian cancer
por: Meyer, T, et al.
Publicado: (2000)

Serum proteins as tumour markers for breast cancer.
por: Mattison, P., et al.
Publicado: (1981)

Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients
por: Weigelt, B, et al.
Publicado: (2003)

Influence of pre-diagnostic cigarette smoking on colorectal cancer survival: overall and by tumour molecular phenotype
por: Zhu, Y, et al.
Publicado: (2014)

KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers
por: Phipps, A I, et al.
Publicado: (2013)

Tumour necrosis factor-alpha expression in tumour islets confers a survival advantage in non-small cell lung cancer
por: Ohri, Chandra M, et al.
Publicado: (2010)

The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer.
por: Lindmark, G., et al.
Publicado: (1995)

The Small Tumour-like Lesions of the Kidney
por: Reese, A. J. M., et al.
Publicado: (1958)

'Tumour volume' as a predictor of survival after resection of non-small-cell lung cancer (NSCLC)
por: Jefferson, M. F., et al.
Publicado: (1996)

Using mathematical models to estimate drug resistance and treatment efficacy via CT scan measurements of tumour volume.
por: Gregory, W. M., et al.
Publicado: (1990)

Comparative values of several tumour markers: example of untreated breast carcinoma.
por: Cazin, J. L., et al.
Publicado: (1990)

Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?
por: Harding, M., et al.
Publicado: (1990)

Early remission is associated with improved survival in patients with inflammatory polyarthritis: results from the Norfolk Arthritis Register
por: Scirè, Carlo A, et al.
Publicado: (2014)

Use of a carbocyanine dye as a marker of functional vasculature in murine tumours.
por: Trotter, M. J., et al.
Publicado: (1989)

Effect of vascular marker Hoechst 33342 on tumour perfusion and cardiovascular function in the mouse.
por: Trotter, M. J., et al.
Publicado: (1990)

Survival, remission, and quality of life in diabetic cats
por: Rothlin‐Zachrisson, Ninni, et al.
Publicado: (2023)

Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer
por: Coulson, J M, et al.
Publicado: (1999)

Lack of effect of interferon alpha 2a upon fluorouracil pharmacokinetics.
por: Seymour, M. T., et al.
Publicado: (1994)

Longitudinal cortical markers of persistence and remission of pediatric PTSD
por: Heyn, Sara A., et al.
Publicado: (2019)

On the relationship between tumour growth rate and survival in non-small cell lung cancer
por: Mistry, Hitesh B.
Publicado: (2017)

Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
por: Kahlert, C, et al.
Publicado: (2009)

The use of erythropoietin in a Jehovah's Witness undergoing major surgery and chemotherapy.
por: Johnson, P. W., et al.
Publicado: (1991)

Tumour Markers: Rationale Use
por: Müller, Mathias M., et al.
Publicado: (2005)

Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions
por: Miédougé, M, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_vk7ute88tn6sa7s3b5cskpmcsu